Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07492329Active, not recruiting
Open-label trial in acute appendicitis (2 arms), sponsored by Sebahattin Celik. Primary endpoint: Treatment success of the initial management strategy at 1 year. Started Nov 2024; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07492329.